Advertisement

Patsy Newitt

Steep declines in colorectal cancer screening after the onset of the COVID-19 pandemic have gastroenterologists concerned about missed opportunities for early detection of colorectal cancer. 

From the emergence of artificial intelligence to declining reimbursements, some of the biggest challenges for gastroenterology were discussed by George Dickstein, MD, a gastroenterologist at Greater Boston Gastroenterology, in an interview with Becker's ASC Review. 

Advertisement

A medical office building housing an ASC in Aventura, Fla., was sold for $16 million, South Florida Business Journal reported Oct. 13. 

CMS issued warnings to 256 hospitals deemed not in compliance with its price transparency rule as of late September.

Advertisement